Zithromax linked to cardiovascular death
A study published in the New England Journal of Medicine May 17, 2012 reports a small increase in cardiovascular deaths, and in the risk of death from any cause, in persons treated with a 5-day course of azithromycin (Zithromax) compared to persons treated with amoxicillin, ciprofloxacin, or no drug. FDA is reviewing the results from this…